mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.062 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |